首页> 外文期刊>Journal of immunology research. >Engagement of the Mannose Receptor by Tumoral Mucins Activates an Immune Suppressive Phenotype in Human Tumor-Associated Macrophages
【24h】

Engagement of the Mannose Receptor by Tumoral Mucins Activates an Immune Suppressive Phenotype in Human Tumor-Associated Macrophages

机译:肿瘤粘蛋白对甘露糖受体的参与激活了人类肿瘤相关巨噬细胞的免疫抑制表型。

获取原文
           

摘要

Tumor-Associated Macrophages (TAMs) are abundantly present in the stroma of solid tumors and modulate several important biological processes, such as neoangiogenesis, cancer cell proliferation and invasion, and suppression of adaptive immune responses. Myeloid C-type lectin receptors (CLRs) constitute a large family of transmembrane carbohydrate-binding receptors that recognize pathogens as well as endogenous glycoproteins. Several lines of evidence demonstrate that some CLRs can inhibit the immune response. In this study we investigated TAM-associated molecules potentially involved in their immune suppressive activity. We found that TAMs isolated from human ovarian carcinoma samples predominantly express the CLRs Dectin-1, MDL-1, MGL, DCIR, and most abundantly the Mannose Receptor (MR). Components of carcinomatous ascites and purified tumoral mucins (CA125 and TAG-72) bound the MR and induced its internalization. MR engagement by tumoral mucins and by an agonist anti-MR antibody modulated cytokine production by TAM toward an immune-suppressive profile increase of IL-10, absence of IL-12, and decrease of the Th1-attracting chemokine CCL3. This study highlights that tumoral mucin-mediated ligation of the MR on infiltrating TAM may contribute to their immune suppressive phenotype.
机译:肿瘤相关巨噬细胞(TAM)大量存在于实体瘤的基质中,并调节一些重要的生物学过程,例如新血管生成,癌细胞的增殖和侵袭以及对适应性免疫反应的抑制。髓样C型凝集素受体(CLR)构成了一大类跨膜碳水化合物结合受体,可识别病原体以及内源糖蛋白。几条证据表明,某些CLR可以抑制免疫反应。在这项研究中,我们研究了TAM相关分子可能参与其免疫抑制活性。我们发现,从人卵巢癌样品中分离出的TAM主要表达CLRs Dectin-1,MDL-1,MGL,DCIR和最丰富的甘露糖受体(MR)。癌性腹水和纯化的肿瘤粘蛋白(CA125和TAG-72)的成分与MR结合并诱导其内在化。肿瘤粘蛋白和激动剂抗MR抗体的MR参与通过TAM调节了细胞因子的产生,从而使IL-10的免疫抑制特性增加,IL-12的缺乏以及Th1吸引趋化因子CCL3的降低。这项研究强调,肿瘤粘蛋白介导的MR在浸润TAM中的结扎可能有助于其免疫抑制表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号